loader2
Partner With Us NRI

Company details

88.00
93.95
87.00
195.00
6M Return -16.16%
1Y Return -13.42%
Mkt Cap.(Cr) 56.10
Volume 12,559
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 12,559

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 28.58 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 24,153.35 -39,474.21
LAST 3M 70,482.80 -53,901.04
LAST 6M 141,118.09 -188,404.80
LAST 12M 210,965.84 -182,647.76

Information

  • About Company
  • Company Info
  • Listing Info
14.54
51.99%
48.636
24.8%
20.82%
Description
  • Auro Laboratories is a manufacturer of Active Pharmaceutical Ingredients (API`s), Intermediates and Generic Formulations. Auro Laboratories was founded and incorporated in 1992 at Mumbai, with a manufacturing facility located at Tarapur, 120 Km from Mumbai. Since inception, the company has focused on providing quality pharmaceuticals while maintaining high manufacturing standards. The company`s primary focus has been on Anti-Diabetic Drugs, which is estimated to be one of the fastest growing therapeutic segments. Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, it also undertake Toll/Custom Manufacturing for API`s and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum. Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia, Middle East and several European Countries. Some of the countries the company exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom. The company has received ISO 9001:2000 and WHO - cGMP certifications. It has also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.

Read More

Registered Address

K-56 MIDC Indl Area, Tarapur Boisar, Thane, Maharashtra, 401506

Tel : 91-22-66635456
Email : auro:aurolabs.com
Website : http://www.aurolabs.com

Registrar

Purva Sharegistry (I) Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 530233
NSE Code :
Book Closure Date (Month) :
BSE Group : XT
ISIN : INE292C01011

ICICIdirect Auro Laboratories Ltd FAQ

You can buy Auro Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Auro Laboratories Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 26, 2022 04:01 PM the closing price of Auro Laboratories Ltd was ₹ 90.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 26, 2022 04:01 PM, the market cap of Auro Laboratories Ltd stood at ₹ 56.10.
The latest PE ratio of Auro Laboratories Ltd as of May 26, 2022 04:01 PM is 14.54
The latest PB ratio of Auro Laboratories Ltd as of May 26, 2022 04:01 PM is 0.54
The 52-week high of Auro Laboratories Ltd is ₹ 195.00 while the 52-week low is ₹ 87.00 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE